Dublin, July 03, 2020 (GLOBE NEWSWIRE) -- The "Progressive supranuclear palsy (PSP) - Market Insights, Epidemiology and Market Forecast-2030" drug pipelines has been added to ResearchAndMarkets.com's ...

Progressive supranuclear palsy (PSP) is a rare brain disorder that affects approximately 6 in 100,000 people worldwide. It causes muscle weakness and affects gait, balance and overall movement, as ...

Dublin, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The "Progressive Supranuclear Palsy (PSP) Therapies Market by Type of Treatment (Curative and Palliative / Symptomatic), and Key Geographical Regions (US, UK, ...

The civil rights leader's organization, the Rainbow PUSH Coalition, announced on Wednesday that Jackson had been hospitalized Scott Olson/Getty Rev. Jesse Jackson has reportedly been hospitalized and ...

BARCELONA, Spain--(BUSINESS WIRE)--Ferrer, a B Corp-certified international pharmaceutical company, has announced the dosing of the first participant in the Phase II clinical trial, PROSPER. The study ...

What is progressive supranuclear palsy (PSP)? Progressive supranuclear palsy (PSP) is a condition that causes both dementia and problems with movement. It is a progressive condition that mainly ...

Progressive supranuclear palsy (PSP) is a rare brain disorder that affects approximately 6 in 100,000 people worldwide. It is a rare disease that may appear similar to some other neurodegenerative ...